Long-Term Reassurance with Negative High-Risk Human Papillomavirus (HR-HPV) and Clear Margins After Large Loop Excision of the Transformation Zone (LLETZ)
Cancers · 01.02.2025 · 17 (3) · 487
DOI: 10.3390/cancers17030487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 01.02.2025. Verfasst von Fatima Heydari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medicine and Translational Research Doctorate Program, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08907 Barcelona, Spain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objective: Women treated with large loop excision of the transformation zone (LLETZ) for cervical intraepithelial neoplasia grade 2-3 (CIN2-3) remain at risk of CIN2-3 and cervical cancer for many years. We assessed the roles of high-risk human papillomavirus (HR-HPV) post-LLETZ, surgical margins, and LLETZ characteristics on the long-term risk of CIN2-3.
Methods
A retrospective observational study was performed using data for 432 women with a histological diagnosis of CIN2-3 treated by LLETZ between 1996 and 2020 and followed-up until October 2021 at Hospital Bellvitge in Barcelona, Spain. Age, surgical margins, 6-month HR-HPV status, excision type, and cone volume/dimensions were analyzed in association with the risk of persistent/recurrent CIN2-3. The cumulative probability of persistent/recurrent CIN2-3 was calculated using the Kaplan–Meier and Cox models.
Results
Persistent/recurrent CIN2-3 was detected in 7.4%, with over 90% found within 5 years post-LLETZ. Predictors of persistent/recurrent CIN2-3 were HR-HPV (HR = 7.36, 95% CI = 3.55–15.26), involved margins (HR = 3.94, 95% CI = 1.68–9.25), uncertain margins (HR = 4.42, 95% CI = 1.55–12.55), and age ≥ 35 years (HR = 2.92, 95% CI = 1.19–7.13). Type 3 excision (p = 0.035) and cone length (p = 0.010) correlated with clear margins. The negative predictive value (NPV) of both negative HR-HPV and clear margins post-LLETZ was 98.7%.
Conclusions
The combination of negative HR-HPV and clear margins post-LLETZ provides stronger reassurance against the risk of persistent/recurrent CIN2-3 than do LLETZ characteristics. However, larger excisions in older women likely reduce the risk of involved margins. Close surveillance, including repeat HR-HPV testing in the first 5 years post-LLETZ, is crucial.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicine and Translational Research Doctorate Program, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08907 Barcelona, Spain.
- Barcelona Institute for Global Health (ISGlobal), Campus Clinic, 08036 Barcelona, Spain.
- Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
- Gynecology Department, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
ORCID-Profile: Maria-Eulalia Fernández-Montolí
Zitieren
APA
Heydari, F., de Sanjosé, S., Peñafiel Muñoz, J., & Fernández-Montolí, M. E. (2025). Long-Term Reassurance with Negative High-Risk Human Papillomavirus (HR-HPV) and Clear Margins After Large Loop Excision of the Transformation Zone (LLETZ). Cancers, 17(3), 487. https://doi.org/10.3390/cancers17030487
Vancouver
Heydari F, de Sanjosé S, Peñafiel Muñoz J, Fernández-Montolí ME. Long-Term Reassurance with Negative High-Risk Human Papillomavirus (HR-HPV) and Clear Margins After Large Loop Excision of the Transformation Zone (LLETZ). Cancers. 2025;17(3):487. doi:10.3390/cancers17030487
BibTeX
@article{Heydari2025,
author = {Heydari, Fatima and de Sanjosé, Silvia and Peñafiel Muñoz, Judith and Fernández-Montolí, Maria-Eulalia},
title = {Long-Term Reassurance with Negative High-Risk Human Papillomavirus (HR-HPV) and Clear Margins After Large Loop Excision of the Transformation Zone (LLETZ)},
journal = {Cancers},
year = {2025},
volume = {17},
number = {3},
pages = {487},
doi = {10.3390/cancers17030487}
}
EUVIMED